Jw Life Science Corp (234080) - Total Liabilities

Latest as of December 2025: ₩97.63 Billion KRW ≈ $66.16 Million USD

Based on the latest financial reports, Jw Life Science Corp (234080) has total liabilities worth ₩97.63 Billion KRW (≈ $66.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jw Life Science Corp - Total Liabilities Trend (2015–2025)

This chart illustrates how Jw Life Science Corp's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Jw Life Science Corp's working capital to evaluate short-term liquidity relative to the company's equity base.

Jw Life Science Corp Competitors by Total Liabilities

The table below lists competitors of Jw Life Science Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Tempore Properties SOCIMI SAU MC:YTEM	Spain	€38.85 Million
Om Holdings Ltd AU:OMH	Australia	AU$407.98 Million
Quartzsea Acquisition Corporati NASDAQ:QSEA	USA	$4.23 Million
Inhibikase Therapeutics Inc NASDAQ:IKT	USA	$6.70 Million
Wallbridge Mining Company Limited TO:WM	Canada	CA$36.21 Million
Yen Sun Technology TWO:6275	Taiwan	NT$2.23 Billion
Microvision Inc NASDAQ:MVIS	USA	$47.57 Million
Thai Steel Cable Public Company Limited BK:TSC	Thailand	฿563.82 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Jw Life Science Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jw Life Science Corp market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jw Life Science Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jw Life Science Corp (2015–2025)

The table below shows the annual total liabilities of Jw Life Science Corp from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩97.63 Billion ≈ $66.16 Million	-21.82%
2024-12-31	₩124.88 Billion ≈ $84.63 Million	+29.48%
2023-12-31	₩96.44 Billion ≈ $65.36 Million	-14.36%
2022-12-31	₩112.61 Billion ≈ $76.31 Million	+28.00%
2021-12-31	₩87.97 Billion ≈ $59.62 Million	+2.32%
2020-12-31	₩85.98 Billion ≈ $58.27 Million	+9.13%
2019-12-31	₩78.79 Billion ≈ $53.39 Million	-13.99%
2018-12-31	₩91.60 Billion ≈ $62.08 Million	-5.01%
2017-12-31	₩96.43 Billion ≈ $65.35 Million	-5.41%
2016-12-31	₩101.94 Billion ≈ $69.08 Million	+5.04%
2015-12-31	₩97.05 Billion ≈ $65.77 Million	--

About Jw Life Science Corp

KO:234080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$119.21 Million

₩175.90 Billion KRW

Market Cap Rank

#18618 Global

#845 in Korea

Share Price

₩11360.00

Change (1 day)

-0.35%

52-Week Range

₩10730.00 - ₩15500.00

All Time High

₩26817.34